Neuroleptic malignant syndrome: the diagnostic dilemma
Journal: Open Journal of Psychiatry & Allied Sciences (Vol.7, No. 2)Publication Date: 2016-06-30
Authors : Ivana Stasevic Karlicic; Jelena Djordjevic; Milena Stasevic; Slavica Djukic Dejanovic; Dragan Pavlovic; Slobodan Jankovic;
Page : 162-165
Keywords : Antipsychotic Agents. Dopamine. Anti-N-Methyl-D-Aspartate Receptor Encephalitis.;
Abstract
Neuroleptic malignant syndrome (NMS) is a life-threatening, often fatal idiosyncratic reaction to neuroleptic or other drug therapies that antagonise the central dopaminergic neurotransmission. The clinical presentation of NMS is very heterogeneous. The lack of specific levels of symptom severity in currently used diagnostic criteria dims the diagnosis of NMS. Therefore differential diagnosis is of priority, because NMS is a diagnosis of exclusion. The aim of this paper is to present a complex clinical picture in a patient that after a differential diagnostic exclusion of other medical conditions and intoxications is diagnosed as NMS. Case reports such as these help raise awareness of this clinical issue.
Other Latest Articles
- A silver lining in strife torn camps of Bodoland, Assam: a case study intersecting gender, disaster, and mental health
- Aripiprazole-induced writer’s cramp: a case report
- Anubhoothi: a psychopathology of unusual sexual experience
- Combined effect of surya namaskar and aerobic exercises to reduce anger among substance dependence subjects
- Comparative study of various socio-demographic variables in patients having type 2 diabetes mellitus with or without depressive disorder: a brief report
Last modified: 2016-07-11 12:36:05